• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Structure-activity relationship of a novel K+ channel opener, KRN4884, and related compounds in porcine coronary artery.

作者信息

Izumi H, Tanaka Y, Okada Y, Ogawa N, Izawa T

机构信息

Pharmaceutical Research Laboratory, Kirin Brewery Co., Ltd., Gunma, Japan.

出版信息

Gen Pharmacol. 1996 Sep;27(6):985-9. doi: 10.1016/0306-3623(95)02139-6.

DOI:10.1016/0306-3623(95)02139-6
PMID:8909979
Abstract
  1. KRN4884 (5-amino-N-[2-(2-chlorophenyl) ethyl]-N'-cyano-3-pyridinecarboxamidine), Ki3005 (5-deamino KRN4884), Ki5624 (2-dechloro KRN4884) and Ki1769 (5-deamino-2-dechloro KRN4884) produced concentration-dependent relaxations in isolated porcine coronary arteries contracted by 25 mM KC1. The order of relaxant potency was KRN4884 > Ki3005 > Ki5624 > Ki1769. 2. The relaxation induced by these compounds was antagonized by glibenclamide; they had almost no effect on coronary arteries contracted by 60 mM KC1. 3. The present results suggest that these pyridinecarboxamidine derivatives have vasodilating ability based on a K+ channel opening action, and that both the amino groups in the pyridine nucleus and the chlorine atom in the benzene nucleus in pyridinecarboxamidine are important for their potency as a K+ channel opener.
摘要

相似文献

1
Structure-activity relationship of a novel K+ channel opener, KRN4884, and related compounds in porcine coronary artery.
Gen Pharmacol. 1996 Sep;27(6):985-9. doi: 10.1016/0306-3623(95)02139-6.
2
In vitro and in vivo vasodilating effects of KRN4884, Ki1769 and Ki3005, pyridinecarboxamidine derivatives.
Fundam Clin Pharmacol. 1997;11(6):561-6. doi: 10.1111/j.1472-8206.1997.tb00861.x.
3
Vasorelaxant action of Ki1769, a new pyridinecarboximidamide, in isolated porcine coronary artery.
Eur J Pharmacol. 1993 Sep 14;241(2-3):177-81. doi: 10.1016/0014-2999(93)90200-2.
4
Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine.与硝苯地平相比,钾通道开放剂KRN4884和利克罗卡林对A23187诱导的大鼠主动脉收缩的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Oct;354(4):460-5. doi: 10.1007/BF00168437.
5
Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
J Cardiovasc Pharmacol. 1995 Aug;26(2):189-97. doi: 10.1097/00005344-199508000-00003.
6
ATP-sensitive potassium channel openers may mimic the effects of hypoxic preconditioning on the coronary artery.
Ann Thorac Surg. 2001 Feb;71(2):642-7. doi: 10.1016/s0003-4975(00)02392-4.
7
Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, pyridinecarboximidamide derivatives, in porcine isolated coronary artery.吡啶甲脒衍生物Ki1769、Ki3315和KRN2391在猪离体冠状动脉中的血管舒张机制比较分析
Gen Pharmacol. 1994 Sep;25(5):941-5. doi: 10.1016/0306-3623(94)90100-7.
8
Pharmacological analysis of the inhibitory effects of KRN2391 on endothelin-1-induced contraction in isolated large coronary artery of the pig.KRN2391对猪离体大冠状动脉中内皮素-1诱导收缩的抑制作用的药理学分析。
Gen Pharmacol. 1994 Sep;25(5):935-9. doi: 10.1016/0306-3623(94)90099-x.
9
Activation of cardiac ATP-sensitive K+ channels by KRN4884, a novel K+ channel opener.新型钾通道开放剂KRN4884对心脏ATP敏感性钾通道的激活作用。
J Pharmacol Exp Ther. 1997 Nov;283(2):770-7.
10
Hypoxic preconditioning in coronary microarteries: role of EDHF and K+ channel openers.
Ann Thorac Surg. 2002 Jul;74(1):143-8. doi: 10.1016/s0003-4975(02)03660-3.

引用本文的文献

1
Characterization and bioactivity of novel calcium antagonists - N-methoxy-benzyl haloperidol quaternary ammonium salt.新型钙拮抗剂——N-甲氧基-苄基氟哌啶醇季铵盐的表征及生物活性
Oncotarget. 2015 Dec 22;6(41):43759-69. doi: 10.18632/oncotarget.6086.
2
Design, synthesis, and pharmacological evaluation of haloperidol derivatives as novel potent calcium channel blockers with vasodilator activity.设计、合成及药理学评价氟哌啶醇衍生物作为新型强效钙通道阻滞剂及血管扩张活性。
PLoS One. 2011;6(11):e27673. doi: 10.1371/journal.pone.0027673. Epub 2011 Nov 16.
3
Effects of potassium channel opener KRN4884 on human conduit arteries used as coronary bypass grafts.
钾通道开放剂KRN4884对用作冠状动脉搭桥移植物的人体 conduit 动脉的影响。 (注:这里“conduit arteries”不太明确准确中文表述,可能是“ conduit动脉”或“输送动脉”之类意思,具体准确含义可能需结合专业背景进一步确定)
Br J Clin Pharmacol. 2000 Aug;50(2):154-60. doi: 10.1046/j.1365-2125.2000.00235.x.
4
Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine.与硝苯地平相比,钾通道开放剂KRN4884和利克罗卡林对A23187诱导的大鼠主动脉收缩的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Oct;354(4):460-5. doi: 10.1007/BF00168437.